Weight-loss drugs could transform healthcare by slowing aging, scientists say
Weight-loss drugs such as semaglutide, marketed under the brand names Wegovy and Ozempic, are set to revolutionise healthcare by potentially slowing down the ageing process and extending healthy lifespans, according to leading scientists. This bold assertion follows recent studies presented at the European Society of Cardiology Conference in London. Previous